Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Campath-1H and Tacrolimus in Liver Transplantation
NCT00166556Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jan 2005
- Primary completion
- Dec 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of alemtuzumab in Liver transplant rejection, sponsored by Mayo Clinic. Started Jan 2005; status: completed.
02
Drugs
alemtuzumab
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00166556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00166556.